Second-trimester double or triple screening for Down syndrome: A comparison of Chinese and Caucasian populations

被引:29
|
作者
Wang, Yuan-Yuan
Luo, Jun
Zhu, Ming-Wei
Liu, Lan-Nv
Ma, Xu
机构
[1] Natl Res Inst Family Planning, WHO Collaborating Ctr Res Human Reprod, Beijing 100081, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Beijing 100037, Peoples R China
[3] Int Peace Hosp Protect Mother & Childs Hlth, China Welf Inst, Shanghai, Peoples R China
[4] Fudan Univ, Obstet & Gynecol Hosp, Med Ctr, Shanghai 200433, Peoples R China
[5] Maternal & Fetal Hlth Hosp, Shanghai, Peoples R China
关键词
Down syndrome; prenatal screening; alpha fetoprotein; human chorionic gonadotrophin; unconjugated estriol;
D O I
10.1016/j.ijgo.2006.04.030
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To compare the performance of double screening (measuring maternal serum levels of a-fetoprotein [AFP] and total beta-human chorionic gonadotrophin [hCG] as markers for Down syndrome) with that of triple screening (also measuring levels of unconjugated estriol [uE3]) in the second trimester of pregnancy, and to compare ethnic variance between Chinese and Caucasian populations. Methods: The study investigated 15096 normal singleton pregnancies and 24 pregnancies affected with Down syndrome. Frequency distributions of AFP, hCG, and uE3 levels were analyzed. Likelihood ratios (LRs) were calculated using the multiple of median value (MoM) of AFP, hCG, and uE3 as variables. After multiplying maternal age risk by the LR values for the markers used in double and triple screening, the specific risks obtained with double and triple screening were estimated. The detection rate (DR) and false-positive rate (FPR) were calculated at different cut-off points. The serum markers' levels were also compared with those of Caucasian women. Results: The median MoM value of hCG was higher in women with affected pregnancies (1.40) than those with unaffected pregnancies (1.00). However, the median MoMs of AFP and uE3 (0.79 and 0.68) were lower in affected than in unaffected pregnancies. At a FPR of 5%, the detection rates reached with double and triple screening were 50% and 66.7%, respectively. Ratios of the 3 serum markers' medians to those in a study with Caucasian women were 1.06 (range = 1.04-1.09) for AFP, 1.14 (range = 1.10-1.17) for hCG, and 1.28 (range = 1.23-1.41) for uE3 for the relevant gestational weeks. Conclusion: Triple screening performed better than double screening in the second trimester. Ethnic variance should be taken into account in Down syndrome screening. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [1] The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies
    Wan, Xiaohua
    Wen, Jiangping
    Song, Xin
    Guo, Yongjun
    Liu, Xiangyi
    Yang, Benshan
    Lu, Xinxin
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (08): : 642 - 647
  • [2] Second-trimester Down's syndrome serum screening: double, triple or quadruple marker testing?
    Harrison, G
    Goldie, D
    ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 : 67 - 72
  • [3] Role of second-trimester ultrasound in screening for Down syndrome
    Cuckle, H.
    Maymon, R.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (03) : 241 - 244
  • [4] Combined second-trimester biochemical and ultrasound screening for Down syndrome
    Benn, PA
    Kaminsky, LM
    Ying, J
    Borgida, AF
    Egan, JFX
    OBSTETRICS AND GYNECOLOGY, 2002, 100 (06): : 1168 - 1176
  • [5] Second-trimester Triple Serum Tests in Women Screening for Down's Syndrome: A Meta Analysis
    Li, Kai
    Ma, Lei
    Xiang, Yan
    Han, Xiaodong
    Li, Long
    Zhu, Baosheng
    PROCEEDINGS OF 2016 IEEE INTERNATIONAL CONFERENCE ON BIG DATA ANALYSIS (ICBDA), 2016, : 315 - 318
  • [6] Incorporation of inhibin-A in second-trimester screening for Down syndrome
    Benn, PA
    Fang, M
    Egan, JFX
    Horne, D
    Collins, R
    OBSTETRICS AND GYNECOLOGY, 2003, 101 (03): : 451 - 454
  • [7] First-trimester or second-trimester screening, or both, for Down's syndrome
    Malone, FD
    Canick, JA
    Ball, RH
    Nyberg, DA
    Comstock, CH
    Bukowski, R
    Berkowitz, RL
    Gross, SJ
    Dugoff, L
    Craigo, SD
    Timor-Tritsch, IE
    Carr, SR
    Wolfe, HM
    Dukes, K
    Bianchi, DW
    Rudnicka, AR
    Hackshaw, AK
    Lambert-Messerlian, G
    Wald, NJ
    D'Alton, ME
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (19): : 2001 - 2011
  • [8] Role of Second-Trimester Genetic Sonography After Down Syndrome Screening
    Aagaard-Tillery, Kjersti M.
    Malone, Fergal D.
    Nyberg, David A.
    Porter, T. Flint
    Cuckle, Howard S.
    Fuchs, Karin
    Sullivan, Lisa
    Comstock, Christine H.
    Saade, George R.
    Eddleman, Keith
    Gross, Susan
    Dugoff, Lorraine
    Craigo, Sabrina D.
    Timor-Tritsch, Ilan E.
    Carr, Stephen R.
    Wolfe, Honor M.
    Bianchi, Diana W.
    D'Alton, Mary E.
    OBSTETRICS AND GYNECOLOGY, 2009, 114 (06): : 1189 - 1196
  • [9] Second-trimester dimeric inhibin-A in Down's syndrome screening
    Spencer, K
    Wallace, EM
    Ritoe, S
    PRENATAL DIAGNOSIS, 1996, 16 (12) : 1101 - 1110
  • [10] Second-trimester maternal serum screening for Down syndrome in Mainland China
    Liao, Can
    Huang, Yining
    Li, Dongzhi
    Song, Shuben
    Yi, Cuixing
    Zhou, Jianying
    PRENATAL DIAGNOSIS, 2006, 26 (13) : 1271 - 1272